About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: October 2008
Weekly Roundup – 10/17/08
lI have been totally dismal about posting this week, but have been occupied with family issues in addition to a trip out of town to Princeton to speak at the Second Annual ExL Pharma Digital Healthcare conference where I spoke … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 10/17/08
Philanthropy and Public Perceptions of the Pharmaceutical Industry
It continues to be a rather strikingly ironic observation that for some the pharmaceutical industry continues to be in the depths of public perceptions despite the fact that it is an industry that provides life and alleviates suffering to so … Continue reading
Posted in Pharma Industry Image
Comments Off on Philanthropy and Public Perceptions of the Pharmaceutical Industry
FDA Announces a Drug Approval with a Press Release
On Friday, October 10, the FDA issued a press release about a new product approval. The approval is called Rapaflo (silodosin) capsules and it is indicated for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also … Continue reading
Posted in FDA Policy
1 Comment
Weekly Roundup – 10/10/08
What a week! Autumn has been lovely, but FALL is all about the stock market. Here is a little bit of what is going on in the pharma biotech world. FDA Issues Draft Guidance – Today the FDA released a … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 10/10/08
Warning Letter Summary – Third Quarter 2008, Part 1
Even the most casual observer will have noticed that across the board, under the Bush Administration, there has been a drastic curtailment by domestic agencies in the enforcement of regulations. Critics and policymakers have assailed the track records of several … Continue reading
Posted in Warning Letters
1 Comment